EVLO - Evelo Biosciences down 39% as 13M share offering begins
2023-08-18 12:29:37 ET
More on Evelo Biosciences
- Circling Back On Evelo Biosciences
- Evelo Biosciences enters into termination and surrender pact with Bio-Rad
- Evelo spikes on $25.5M private placement
- Evelo slumps ~40% as eczema drug program abandoned after trial fails; cuts staff
- Evelo drops 23% as atopic dermatitis trial fails; announces layoffs
For further details see:
Evelo Biosciences down 39% as 13M share offering begins